Correlation Between Climb Bio and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Climb Bio and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Climb Bio and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Climb Bio and Vincerx Pharma, you can compare the effects of market volatilities on Climb Bio and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Climb Bio with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Climb Bio and Vincerx Pharma.

Diversification Opportunities for Climb Bio and Vincerx Pharma

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Climb and Vincerx is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Climb Bio and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Climb Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Climb Bio are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Climb Bio i.e., Climb Bio and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Climb Bio and Vincerx Pharma

Given the investment horizon of 90 days Climb Bio is expected to generate 0.69 times more return on investment than Vincerx Pharma. However, Climb Bio is 1.44 times less risky than Vincerx Pharma. It trades about -0.28 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.24 per unit of risk. If you would invest  800.00  in Climb Bio on September 12, 2024 and sell it today you would lose (490.00) from holding Climb Bio or give up 61.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Climb Bio  vs.  Vincerx Pharma

 Performance 
       Timeline  
Climb Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Climb Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Climb Bio and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Climb Bio and Vincerx Pharma

The main advantage of trading using opposite Climb Bio and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Climb Bio position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind Climb Bio and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume